MedTrace Logo

Torque Teno Virus: A Biomarker of Immunosuppression

NCT05756036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 268

Last updated 2026-02-23

No results posted yet for this study

Summary

To seek an association between Torque Teno Virus DNA titres resulting from under or over-immunosuppression in a kidney allograft recipient, Graft rejection, both cell-mediated rejection and antibody-mediated rejection, donor-specific antibodies (DSA), the incidence of BK viraemia and BK nephropathy, CMV infection or diseases and PCP infection and the number of circulating NK, B and T lymphocyte subtypes.

Conditions

  • Renal Transplant Rejection
  • Immunosuppression
  • Renal Transplant Failure
  • Renal Transplant Infection

Interventions

OTHER

None Observational study

Non interventional study

Sponsors & Collaborators

  • Queen Mary University of London

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756036 on ClinicalTrials.gov